Generic substitution: An opportunity to educate consumers

Article

In a recent survey by Medco Health Solutions Inc., only 66% of 1,092 patients with insurance surveyed "agreed that a generic drug is the same as the brand-name medication - many patients are still not comfortable using a generic and others still consider brand-name drugs to be superior."

Key Points

Last October, my 15-year-old son worried that his acne could no longer be managed with the over-the-counter products he'd been using for 2 years. His dermatologist agreed and suggested isotretinoin, which involved monthly blood testing and a patient registry agreement. I was surprised that the co-pay was only $15 - until I realized that my son was receiving not the branded version, Accutane, but the generic substitute, Amnesteem.

There is no doubt that generic substitution offers payers and consumers a chance to save substantially on prescription-drug spending. With the average price of a generic drug 70% less than its brand-name equivalent, generic manufacturers have made it possible to offer consumers safe, effective solutions with bioequivalent products.

However, in a recent survey by Medco Health Solutions Inc., only 66% of 1,092 patients with insurance surveyed "agreed that a generic drug is the same as the brand-name medication - many patients are still not comfortable using a generic and others still consider brand-name drugs to be superior."

Is the generic working?

At that point, Tim wouldn't leave the house without putting on ivory foundation. If he ran out of the makeup, I had to run to the drugstore for it or he wouldn't go to school. I heard from other parents whose children had taken isotretinoin that it cleared acne very quickly. I started to wonder whether the generic was really working.

It has been 7 months since my son began taking isotretinoin, and I am now confident that the generic equivalent of Accutane works (see the before and after photos above). In a few months, Tim will be finished with the systemic therapy, and one consumer, at least, will have been reassured of the efficacy of generic drugs.

JULIA TALSMA
EDITOR-IN-CHIEF, DRUG TOPICS

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.